Literature DB >> 16330544

Chaperoning checkpoint kinase 1 (Chk1), an Hsp90 client, with purified chaperones.

Sonnet J H Arlander1, Sara J Felts, Jill M Wagner, Bridget Stensgard, David O Toft, Larry M Karnitz.   

Abstract

Checkpoint kinase 1 (Chk1), a serine/threonine kinase that regulates DNA damage checkpoints, is destabilized when heat shock protein 90 (Hsp90) is inhibited, suggesting that Chk1 is an Hsp90 client. In the present work we examined the interplay between Chk1 and Hsp90 in intact cells, identified a source of unchaperoned Chk1, and report the in vitro chaperoning of Chk1 in reticulocyte lysates and with purified chaperones and co-chaperones. We find that bacterially expressed Chk1 is post-translationally chaperoned to an active kinase. This reaction minimally requires Hsp90, Hsp70, Hsp40, Cdc37, and the protein kinase CK2. The co-chaperone Hop, although not essential for the activation of Chk1 in vitro, enhanced the chaperoning process, whereas the co-chaperone p23 did not stimulate the chaperoning reaction. Additionally, we found that the C-terminal regulatory domain of Chk1 affects the association of Chk1 with Hsp90. Collectively these results provide new insights into Hsp90-dependent chaperoning of a client kinase and identify a novel, biochemically tractable model system that will be useful to further dissect the Hsp90-dependent chaperoning of this important and ubiquitous class of Hsp90 clients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16330544     DOI: 10.1074/jbc.M508687200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

Review 1.  Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases.

Authors:  Daniel W Neef; Alex M Jaeger; Dennis J Thiele
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

2.  ATP binding to Hsp90 is sufficient for effective chaperoning of p53 protein.

Authors:  Dawid Walerych; Malgorzata Gutkowska; Marcin P Klejman; Bartosz Wawrzynow; Zuzanna Tracz; Milena Wiech; Maciej Zylicz; Alicja Zylicz
Journal:  J Biol Chem       Date:  2010-08-05       Impact factor: 5.157

Review 3.  New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential.

Authors:  Yanyan Li; Tao Zhang; Steven J Schwartz; Duxin Sun
Journal:  Drug Resist Updat       Date:  2009 Feb-Apr       Impact factor: 18.500

4.  The Yeast Hsp70 Cochaperone Ydj1 Regulates Functional Distinction of Ssa Hsp70s in the Hsp90 Chaperoning Pathway.

Authors:  Deepika Gaur; Prashant Singh; Jyoti Guleria; Arpit Gupta; Satinderdeep Kaur; Deepak Sharma
Journal:  Genetics       Date:  2020-04-16       Impact factor: 4.562

5.  Evaluating CK2 activity with the antibody specific for the CK2-phosphorylated form of a kinase-targeting cochaperone Cdc37.

Authors:  Yoshihiko Miyata; Eisuke Nishida
Journal:  Mol Cell Biochem       Date:  2008-06-20       Impact factor: 3.396

Review 6.  Heat-shock proteins: chaperoning DNA repair.

Authors:  Laurence Dubrez; Sébastien Causse; Natalia Borges Bonan; Baptiste Dumétier; Carmen Garrido
Journal:  Oncogene       Date:  2019-09-20       Impact factor: 9.867

7.  Checkpoint kinase 1 is negatively regulated by miR-497 in hepatocellular carcinoma.

Authors:  Yin Xie; Rong-Rong Wei; Guo-Liang Huang; Mei-Yin Zhang; Yun-Fei Yuan; Hui-Yun Wang
Journal:  Med Oncol       Date:  2014-01-25       Impact factor: 3.064

8.  Designed Hsp90 heterodimers reveal an asymmetric ATPase-driven mechanism in vivo.

Authors:  Parul Mishra; Daniel N A Bolon
Journal:  Mol Cell       Date:  2014-01-23       Impact factor: 17.970

9.  Hsp90 charged-linker truncation reverses the functional consequences of weakened hydrophobic contacts in the N domain.

Authors:  Shinji Tsutsumi; Mehdi Mollapour; Christian Graf; Chung-Tien Lee; Bradley T Scroggins; Wanping Xu; Lenka Haslerova; Martin Hessling; Anna A Konstantinova; Jane B Trepel; Barry Panaretou; Johannes Buchner; Matthias P Mayer; Chrisostomos Prodromou; Len Neckers
Journal:  Nat Struct Mol Biol       Date:  2009-10-18       Impact factor: 15.369

10.  90-kDa heat shock protein inhibition abrogates the topoisomerase I poison-induced G2/M checkpoint in p53-null tumor cells by depleting Chk1 and Wee1.

Authors:  Archie N Tse; Tahir N Sheikh; Ho Alan; Ting-Chao Chou; Gary K Schwartz
Journal:  Mol Pharmacol       Date:  2008-09-26       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.